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tients older than men, sudden chest pain symptoms women is obvious
than men. while symptoms of irritable male more common. aortic
intramural hematoma is more common in women. Suffering from
acute type AAD women patients have higher operative mortality.
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Kv4.3 Expression Improves Cardiac Contraction Without Inhibition of
Relaxation in Heart Failure
Yanggan Wang
Zhongnan Hospital of Wuhan University
OBJECTIVES To test whether expression of Kv4.3 in HF ventricular
myocytes would improve cardiac contraction without affecting
relaxation by inhibition of membrane associated CaMKII.
METHODS HF was generated in mice by thoracic aortic binding and
Kv4.3 was expressed in HF ventricular myocytes by left ventricular
adenoviral injection with Ad-Kv4.3 (Ad-b-gal injection was used as
control). [Ca2+]i and sarcomere length were measured by IonOptix
Ca2+ image system. Myoﬁlament sensitivity to Ca2+ was assessed
by measuring the gradient of cell length-fura2 trajectory during
contraction and late relaxation.
RESULTS HF ventricular myocytes with Kv4.3 expression presented a
signiﬁcant increase in fractional shortening and Ca2+ transient with
a reduction in diastolic SR Ca2+ leak, and a recovery of frequency-
dependent acceleration of relaxation (FDAR), an intrinsic mechanism
allowing faster ventricular relaxation and diastolic ﬁlling at fast heart
rates. In contrast to KN93, a pharmacological CaMKII inhibitor, Kv4.3
expression did not affect myoﬁlament sensitivity to Ca2+, assessed by
the changes of length-fura2 trajectory gradients. In line with this, a
phospho-Ser-antibody showed that unlike KN93, which signiﬁcantly
reduced phosphorylation in the Tn-I that co-immunoprecipitated with
CaMKII, Kv4.3 expression did not alter Tn-I phosphorylation. In vivo
study showed that Kv4.3 expression increased EF from 45  1% in HF
mice transfected with Ad-b-gal (n¼11) to 73  2% in mice transfected
with Ad-Kv4.3 (n¼10, p<0.05), while the E/E’ ratio was unchanged
(39  2 vs. 35  2, p>0.05).
CONCLUSIONS Our results suggest that Kv4.3 expression improves
myocardial contraction without detrimental effect on cardiac relaxa-
tion. Instead, it recovers FDAR.GW26-e4022
SRY Gene Transferred by Extracellular Vesicles Accelerates
Atherosclerosis by Promotion of Leukocyte Adherence to Endothelial Cells
Jin Cai, Chunyu Zeng
Department of Cardiology, Daping Hospital, The Third Military Medical
University, Chongqing, China
OBJECTIVES Extracellular vesicles (EVs) participate in important
biological processes, including horizontal transfer of borne molecules
among neighboring cells. Our previous study showed the existence of
DNA in EVs that have the ability to inﬂuence the function of recipient
cells by increasing DNA-coding mRNA and protein levels. SRY (sex
determining region, Y), a gene in the Y chromosome responsible for
increasing expression of angiotensin II and noradrenaline, is associ-
ated with risk of coronary artery disease (CAD) in men. We hypothe-
size that SRY DNAs in plasma EVs is involved in the pathogenesis of
atherosclerosis by the transfer of SRY DNA to recipient cells, e.g.,
leukocytes and endothelial cells, and increased adherence of leuko-
cytes to endothelial cells.
We set out to investigate whether and how SRY (sex determining
region, Y) DNAs in plasma extracellular vesicle (EVs) is involved in the
pathogenesis of atherosclerosis.
METHODS PCR and gene sequencing found SRY gene fragment in
plasma EVs from male but not from female patients; EVs from male
patients with coronary artery disease (CAD) had higher SRY gene copy
number (GCN) than healthy subjects.
RESULTS Additional studies found that leukocytes, the major source
of plasma EVs, had higher SRY GCN and mRNA and protein expression
in male CAD patients than controls. After incubation with EVs from
SRY-transfected HEK293 cells, monocytes (THP-1) and endothelial
cells (HUVECs), which do not endogenously express SRY protein, were
found to express newly-synthesized SRY protein. This resulted in an
increase in adherence factors, CD11-a in THP-1 cells and ICAM-1 in
HUVECs. Electrophoretic mobility shift assay showed that SRY protein
increased the promoter activity of CD11-a in THP-1 cells and ICAM-1 in
HUVECs. There was an increase in THP-1 cells adherent to HUVECsafter incubation with SRY-EVs. SRY DNAs transferred from EVs have
pathophysiological signiﬁcance in vivo; injection of SRY EVs to
ApoE-/- mice accelerated atherosclerosis.
CONCLUSIONS The SRY gene in plasma EVs transferred to vascular
endothelial cells may play an important role in the pathogenesis
of atherosclerosis; this mechanism provides a new approach to the
understanding of inheritable CAD in men.
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Role of Monocyte/Macrophage in TRPV1 Ablation-Induced Renal Injury in
Salt-Sensitive Hypertension
Youping Wang, Mingjun Zhu, Leilei Fan, Miaomiao Fan, Lin Cui,
Xiaoxiao Wang, Shiyang Xie, Si Shen
Central Laboratory and Division of Cardiology, First Afﬁliated Hospital,
Henan University of Traditional Chinese Medicine, Zhengzhou,
450000, China
OBJECTIVES Our studies show that deletion of the transient receptor
potential vanilloid type 1 (TRPV1) gene aggravates deoxycorticoster-
one acetate (DOCA)-salt hypertension-induced renal injury, which is
associated with increased renal monocyte chemoattractant protein-1
(MCP-1) production and monocyte/macrophage inﬁltration. The
results suggest that TRPV1 ablation-induced aggravation of renal
injury in DOCA-salt hypertension may be the result of enhanced renal
monocyte/macrophage inﬁltration that is dependent of the MCP-1/C-C
chemokine receptor 2 (CCR2) signaling pathway. Therefore, we
hypothesized that MCP-1/CCR2-mediated monocyte/macrophage
inﬁltration is a critical determinant of TRPV1 ablation-induced renal
injury in salt-sensitive hypertension.
METHODS We induced salt-sensitive hypertension for 4 weeks by
uninephrectomy and DOCA-salt in wild type (WT) and TRPV1-null
mutant (TRPV1-/-) mice with or without RS504393, a selective CCR2
antagonist.
RESULTS DOCA-salt treatment increased systolic blood pressure
(SBP) to the same degree in both strains, but increased urinary
excretion of albumin and 8-isoprostane and decreased creatinine
clearance with greater magnitude in TRPV1-/-mice compared to WT
mice (89.35.2 vs. 26.53.4 mg/24h; 4.240.45 vs. 1.520.21 ng/24h;
9819 vs. 16814 ml/24h, P<0.05). DOCA-salt treatment also caused
renal glomerulosclerosis, tubulointerstitial injury, collagen deposi-
tion, monocyte/macrophage inﬁltration, proinﬂammatory cytokine
and chemokine production, and NF-kB activation in greater degree in
TRPV1-/- mice compared to WT mice (glomerulosclerosis index:
0.780.15 vs. 0.350.14; tubulointerstitial injury score: 3.371.0 vs.
2.010.49; collagen content: 21.82.3 vs. 13.82.4 mg/mg dry tissue;
monocyte/macrophage inﬁltration: 744 vs. 425 cells/mm2; TNF-a:
1.030.22 vs. 0.760.21 pg/mg protein; MCP-1: 10.351.19 vs.
6.000.86 pg/mg protein; p65-NF-kB protein: 545 vs. 363 ng/mg
protein, P<0.05). Blockade of the CCR2 with RS504393 (4 mg/kg) had
no effect on SBP in DOCA-salt-treated WT or TRPV1-/- mice compared
to their respective controls. However, treatment with RS504393
ameliorated renal dysfunction and morphological damage, and pre-
vented the increase in monocyte/macrophage inﬁltration, cytokine/
chemokine production, and NF-kB activity in both DOCA-salt hyper-
tensive strains with a greater effect in DOCA-salt-treated TRPV1-/-
compared to DOCA-salt-treated WT mice.
CONCLUSIONS Our data showed that blockade of CCR2 with
RS504393 attenuated DOCA-salt hypertension-induced renal injury in
WT and TRPV1-/- mice independently of their effects on blood pres-
sure. The protective effect was greater in TRPV1-/- mice compared to
WT mice. The results suggest that deletion of TRPV1 aggravated
salt-sensitive hypertension-induced renal damage possibly via
enhancement of the MCP-1/CCR2-mediated monocyte/macrophage
inﬁltration. [This work was supported by a grant from the National
Natural Science Foundation of China (No. 81170243)].
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Exploring the Active Ingredients in Chinese Yellow Wine Which Could
Inhibit the Progress of Atherosclerosis in LDLR Knockout Mice
Liping Meng,1,2 Xiaoya Zhai,2 Chenjian Jiang,2 Zheng Ji,2 Yan Guo,2
Jufang Chi,2 Hangyuan Guo1,2
1Shaoxing People’s Hospital; 2The First Clinical Medical College of
Wenzhou Medical University
OBJECTIVES To explore the active ingredients in Chinese yellow
wine which could inhibit the progress of atherosclerosis in LDLR
knockout mice.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5 C7METHODS Six weeks old LDLR-/- male mice (n¼56) were randomly
allocated into 7 groups (8 mice in each group): normal control group (NC),
high fat group (HF), high fat and yellow wine oligosaccharides modula-
tion group (HFYWO), High fat and yellow wine polypeptides modulation
group (HFYWPP), high fat and yellow wine polyphenols modulation
group (HFYWP), high fat and alcohol modulation group (HFA), high fat
and yellow wine modulation group (HFYW). After 16 weeks intervention,
mice were sacriﬁced. The levels of serum lipids were examined. The
morphological changes of aorta artery were observed under microscope.
The expressions of matrix metalloproteinase 2 (MMP-2), matrix metal-
loproteinase 9 (MMP-9), tissue inhibitor of metalloproteinase2 (TIMP-2)
were determined by Western blot. The activations of MMP-2, MMP-9
were determined by Gelatin Zymography.
RESULTS Compared to NC, high fat diet could rise the serum lipid
level, improve the atherosclerosis lesion area and increase the
expression and activation of MMP-2 and MMP-9. Compared with HF,
the level of LDL-C, TG and TC in the serum of mice were decreased in
HFYWP, HFYWPP and HFYW, P<0.05. The atherosclerosis lesion area
in HFYWPP (10.11.23), HFYWP (7.30.86) and HFYW (5.10.34) were
signiﬁcantly smaller Compared with HF (15.31.84), P<0.05. Yellow
wine polypeptides, polyphenols and Chinese yellow wine could
inhibit the expression and activation of MMP-2 and MMP-9 compared
with HF, P<0.05. There is no signiﬁcant difference between each
group on the expression of TIMP-2.
CONCLUSIONS Polypeptides and polyphenols in the Chinese yellow
wine could inhibit the high fat diet induced progression of athero-
sclerosis in LDLR-/- mice, the mechanisms may be that these in-
gredients in the yellow wine could regulate blood lipid and keep the
balance between MMPs and TIMPs.
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Effects of Yellow Wine on Rat Vascular Endothelial Cells Induced by TNF-a
Fei Zhao, Liping Meng, Yan Guo, Hangyuan Guo
Department of Cardiology, Shaoxing People’s Hospital, Shaoxing
Hospital of Zhejiang University
OBJECTIVES To determine similarities in effect of yellow wine as
compared statin and the possibility that yellow wine on rat vascular
endothelial cells induced by TNF-a.
METHODS Isolation, cultivation, puriﬁcation and identiﬁcation of
vascular endothelial cells of rat thoracic aorta in vitro were conducted.
The passages 3 of VECs were used in all studies. The viability of VECs
was determined and the optimal concentration of the wine was
selected using MTT method. Then we divided cells into 9 groups:
control, TNF-a, TNF-a+ rosuvastatin (10 umol/L), TNF-a+ethanol
0.5%, TNF-a+yellow wine 0.5%, TNF-a+ethanol 1.0%, TNF-a+yellow
wine 1.0%, TNF-a+ethanol 1.5%, and TNF-a+yellow wine 1.5% and the
cells were given the corresponding treatment. NO production of cul-
ture supernatant was determined by nitrate reduction method and
eNOS activity of cells was measured by chemical colorimetric method
after the corresponding treatment for 24 h. The expression of eNOS,
iNOS, and ICAM-1 protein were detected by western blotting after the
corresponding treatment for 48 h.
RESULTS
1. Compared with control group, the NO production in TNF-a group was
decreased signiﬁcantly (P<0.05). Compared with TNF-a group, the
rosuvastatin, yellow wine 1.0% and yellow wine 1.5% groups can in-
crease NO production (P<0.01 or P<0.05). The effect in ethanol 0.5%,
1.0%, 1.5% and yellow wine 0.5% groups was not signiﬁcant.
2. Compared with control group, eNOS activity in TNF-a group was
signiﬁcantly decreased (P<0.05). Compared with TNF-a group, eNOS
activity in rosuvastatin, yellow wine 1.0% and yellow wine 1.5%
groups were signiﬁcantly increased (P<0.01 or P<0.05). However,
there was no signiﬁcant difference among ethanol 0.5%, 1.0%, 1.5%
and yellow wine 0.5% groups.
3. Compared with the TNF-a group, eNOS protein expression in the
rosuvastatin, and yellow wine 1.0%, and 1.5% groups were signiﬁ-
cantly increased (P<0.01). Protein expression of iNOS and ICAM-1 in
the rosuvastatin, yellow wine 1.0%, and 1.5% groups were signiﬁ-
cantly decreased (P<0.01). Compared with the rosuvastatin group,
eNOS, iNOS, and ICAM-1 protein expression in the yellow wine (0.5%
-1.5%) groups were signiﬁcantly different (P<0.01 or P<0.05).
CONCLUSIONS
1. TNF-a can reduce NO production of culture supernatant in VECs,
inhibit the eNOS activity and the expression of eNOS protein, and
enhance the expression of iNOS and ICAM-1 protein. It promotes the
development of atherosclerosis by causing endothelial dysfunction.2. Yellow wine and rosuvastatin can improve vascular endothelial
function by increasing NO production of culture supernatant,
enhancing eNOS activity and expression of eNOS protein and inhib-
iting iNOS and ICAM-1 protein levels.
3. Yellow wine is similar to the role of rosuvastatin.
4. The result suggests that yellow wine might affect the development
of atherosclerosis through this mechanism and contribute to its
beneﬁcial effects on the cardiovascular system.GW26-e0687
The Endoplasmic Reticulum Stress Signaling Pathways in Protection of
Myocardium Ischemia/Reperfusion Injury Model Rats by Pioglitazone
Huanzhen Chen,1 Xiangli Cui,2 Xiuping Jiang,1 Yan Li,1 Wenyan Ma1
1The First Hospital of Shanxi Medical University; 2Shanxi Medical
University
OBJECTIVES To observe inﬂuence of Pioglitazone on the changes of
expression of GRP78 JNK/ p-JNK and caspase-12 in Ischemia reper-
fusion in rats, and discuss the myocardial protective effect of piogli-
tazone to the endoplasmic reticulum stress way through the JNK
pathway.
METHODS Forty male rats were randomly divided into four groups:
sham operation group (n¼10), ischemia-reperfusion group (n¼10),
pioglitazone 10 mg treated group (n¼10), pioglitazone 10 mg treated
and using SP600125 group (n¼10). Left anterior descending coronary
artery was ligated for 30 min and reperfused for 2 hour to establish the
model of ischemia-reperfusion. The number of myocardial apoptotic
cells were detected by TUNEL staining, the expression of GRP78 and
caspase-12 protein were detected by immunohistochemical staining.
Western blot was performed to detect the expression of JNK and
p-JNK.
RESULTS
1. Myocardial cell apoptosis index myocardial cell apoptosis index in
ischemia reperfusion group is (35.982.6%), sham operation group
(1.870.13) %, pioglitazone group (23.701.08) %, pioglitazone com-
bined SP600125 group (19.160.44)%. Pioglitazone group AI was
lower compared to the ischemia reperfusion group (P < 0.05), but
higher than that of the sham operation group (P < 0.05). Though the
pioglitazone combined SP600125 group AI is higher than that of
ischemia reperfusion group, the difference was not statistically sig-
niﬁcant (P ¼ 0.05).
2. 2 GRP78 protein average integral optical density AIOD AIOD in
ischemia-reperfusion group is 0.4370.166, in sham operation group
is 0.0270.045,in pioglitazone group is 0.4000.107,in pioglitazone
combined SP60025 group is 0.3850.237. The expression of GRP78 in
pioglitazone group and Pioglitazone combined SP60025 group were
lower than in ischemia reperfusion group (P < 0.05), but higher than
that of the sham operation group (P < 0.05).
3. Caspase-12protein average integral optical density For AIOD,
ischemia-reperfusion group is 1.3210.081, sham operation group is
0.1730.070, pioglitazone group is 0.7460.076, pioglitazone com-
bined SP60025 group is 0.5140.059, the expression of GRP78 in
pioglitazone group and Pioglitazone combined SP60025 group were
lower than in ischemia reperfusion group (P < 0.05), but higher than
that of the sham operation group (P < 0.05).
4. JNK, p-JNK protein expression Compared with the sham group JNK
protein expression did not change signiﬁcantly, but its activated form
p-JNK expression changes signiﬁcantly, compared with the sham
group p-JNK expression of I/R group increased 3.46 -fold (P < 0.05),
compared with I/R group p-JNK of pio group downregulated 1.22 -fold
(P <0.05), compared with pio group p-JNK of pioglitazone combined
SP600125 downregulated 0.78 -fold (P <0.05)
CONCLUSIONS Ischemia-reperfusion can activate JNK access and
induce severe ER then aggravate cell apoptosis induced by ERS. Pio-
glitazone could reduce cell apoptosis induced by ERS, which are
important protection factors, are mediated by JNK.
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Macrophage Migration Inhibitory Factor (MIF) Promotes the Expression
of GLUT4 Glucose Transporter Through MEF2 and Zac1 in Cardiomyocytes
Zhixin Shan, Shulin Wu
Guangdong General Hospital, Guangdong Cardiovascular Institute
OBJECTIVES Evidence shows that both macrophage migration
inhibitory factor (MIF) and GLUT4 glucose transporter are involved in
